This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Optimism Of Cannabis Patients Creates More Demand For Phytiva Brand Of Cannabinoid Solutions As Illinois And New Hampshire Take Key Legislative Steps Toward Legalization Of Medical Cannabis

DALLAS, March 8, 2013 /PRNewswire/ -- X-Change Corp. (NASDAQ OTC: XCHC), a U.S. Company specializing in cannabinoid formulation-based health solutions through its Phytiva brand product lines is pleased that in the last two days, medical cannabis bills have easily advanced out of key committees to full votes in both the Illinois General Assembly and the New Hampshire House of Representatives.  These actions toward providing safe access to medical cannabis for people with unmet medical needs in both Illinois with House Bill 0030 and New Hampshire with House Bill 442-FN continue the trend of state-by-state recognition of the medical value of cannabis and cannabinoids.

Currently 18 states and the District of Columbia have enacted laws which approve and regulate the use medical cannabis, two of which are considering expansion of existing law.  In addition to Illinois and New Hampshire, another 17 states have pending legislation to enact a form of legal protection for medicinal cannabis patients.  Recent national polls show that approximately 80% of Americans are in favor of medicinal cannabis legalization.

"We are incredibly encouraged that more than two-thirds of U.S. states have adopted laws or are formally considering bills to help patients in need of medical cannabis for their ailments.  We commend the most recent bipartisan developments in Illinois and New Hampshire.  As more and more jurisdictions provide legal safe access frameworks, the Company intends to enter these markets, not only in the United States but also abroad, with its Phytiva brand product lines," stated Robert Kane, President and CEO of X-Change Corp.

About Phytiva Brand Product Lines

Phytiva expects to develop and launch various innovative product lines.  The first is the Phytiva Brand European Line, which is an inventive line that is a hybrid of a proven, existing product line that has been well-managed and conservatively-run for over a decade with a cannabinoid based product line, utilizing the unique and potent benefits of cannabinoids.  Phytiva's revolutionary formulations target not just the symptom, but also the cause.  Cannabinoids and their sources constitute an ideal base for therapeutic solutions and have been utilized for centuries in skin and other remedies for human ailments.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs